Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients
Crossref DOI link: https://doi.org/10.1007/s12094-015-1300-4
Published Online: 2015-06-04
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Y.
Li, R. Q.
Ai, Y. Q.
Zhang, J.
Zhao, P. Z.
Li, Y. F.
He, W. J.
Xia, Y. X.
Li, W. H.
Text and Data Mining valid from 2015-06-04